Authors:
Lovett, BD
Strumberg, D
Blair, IA
Pang, SK
Burden, DA
Megonigal, MD
Rappaport, EF
Rebbeck, TR
Osheroff, N
Pommier, YG
Felix, CA
Citation: Bd. Lovett et al., Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints, BIOCHEM, 40(5), 2001, pp. 1159-1170
Authors:
Byl, JAW
Fortune, JM
Burden, DA
Nitiss, JL
Utsugi, T
Yamada, Y
Osheroff, N
Citation: Jaw. Byl et al., DNA topoisomerases as targets for the anticancer drug TAS-103: Primary cellular target and DNA cleavage enhancement, BIOCHEM, 38(47), 1999, pp. 15573-15579
Citation: Ps. Kingma et al., Binding of etoposide to topoisomerase II in the absence of DNA: Decreased affinity as a mechanism of drug resistance, BIOCHEM, 38(12), 1999, pp. 3457-3461